Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)Seeking Alpha • 01/14/25
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the marketCNBC • 01/08/25
Asher Bio Announces Clinical Trial Collaboration and Supply Agreement on Etakafusp Alfa (AB248) in Combination with Bispecific T-cell Engager in Patients with Small Cell Lung CancerBusiness Wire • 01/08/25
Amgen's IMDYLLTRA®▼ (tarlatamab) Granted a Conditional Marketing Authorisation for Third-Line Treatment of Extensive-Stage Small Cell Lung Cancer in the United KingdomBusiness Wire • 01/06/25
It Is Worth It to Buy the 3 Highest Paying Dividend Stocks in the Dow Jones?24/7 Wall Street • 01/02/25
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key InsightsZacks Investment Research • 12/31/24
Dow Losing Streak Longest in 50 Years: Grab These Bargain Blue-Chip Dividend Stocks Now24/7 Wall Street • 12/19/24
PESG Releases Market Update: Silexion Therapeutics Advances KRAS-Targeting Therapies with New Collaboration As Industry Demand for Precision Oncology Solutions RisesBusiness Wire • 12/17/24